The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: Bevacizumab     Injury: Acute coronary syndrome     Quarter: 2016Q3

  |<   1/2   << Previous Page   Page 1  

Total Records: 4     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
94583572 Bevacizumab Acute coronary syndrome ROCHE 66.00 YR F 54 KG 20160929 US
125509871 Bevacizumab Acute coronary syndrome ROCHE 0.00 0 20160713 GR
127904181 Bevacizumab Acute coronary syndrome ROCHE 69.00 YR F 0 20160928 US
127916341 Bevacizumab Acute coronary syndrome ROCHE 39.00 YR F 0 20160929 US

  |<   1/2   << Previous Page   Page 1  

Total Records: 4     Number of Pages: 1

Execution Time: 0.037333965301514 seconds (ucode:5115606). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.